Azacitidine compared to conventional chemotherapy in consolidation of elderly patients (> 65 years) with AML in first complete remission
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Azacitidine (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 10 Apr 2016 Status changed from completed to discontinued, as reported by European Clinical Trials Database record.
- 04 Jul 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database record.
- 19 Feb 2013 New trial record